相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4
Carolien Out et al.
JOURNAL OF HEPATOLOGY (2015)
Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse
Jen-Chieh Chuang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1
Cedric Le May et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression
Rex A. Parker et al.
JOURNAL OF LIPID RESEARCH (2013)
Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 mice
Rodrigo Neto-Ferreira et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Patrizia Gazzerro et al.
PHARMACOLOGICAL REVIEWS (2012)
Reverse Cholesterol Transport Revisited Contribution of Biliary Versus Intestinal Cholesterol Excretion
Gemma Brufau et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL
Marta Marchesi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Quantifying cholesterol synthesis in vivo using 2H2O: enabling back-to-back studies in the same subject
Stephen F. Previs et al.
JOURNAL OF LIPID RESEARCH (2011)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Association of plasma phytosterol concentrations with incident coronary heart disease Data from the CORA study, a case-control study of coronary artery disease in women
Eberhard Windler et al.
ATHEROSCLEROSIS (2009)
Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy
Michael Bodmer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol
Jelske N. van der Veen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
BrightStat.com: Free statistics online
Daniel Stricker
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2008)
Analysis of five HMG-CoA reductase inhibitors-atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin:: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies
MK Pasha et al.
BIOMEDICAL CHROMATOGRAPHY (2006)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
Update on statins: 2003
CJ Vaughan et al.
CIRCULATION (2004)
Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes
JD Horton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Pharmacologic characteristics of statins
JM McKenney
CLINICAL CARDIOLOGY (2003)
Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment
TA Miettinen et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Structural mechanism for statin inhibit ion of 3-hydroxy-3-methylglutaryl coenzyme A reductase
ES Istvan
AMERICAN HEART JOURNAL (2002)
High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production
N Roglans et al.
LIPIDS (2002)
Mdr P-glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin-induced mouse model of erythropoietic Protoporphyria
T Plösch et al.
HEPATOLOGY (2002)
Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells
T Funatsu et al.
ATHEROSCLEROSIS (2001)
The sterol regulatory element-binding protein pathway: control of lipid homeostasis through regulated intracellular transport
J Sakai et al.
CURRENT OPINION IN LIPIDOLOGY (2001)